Showing all 3 results
-
Skyrizi
FreeTrade Name Skyrizi Active Ingredient Risankizumab Power 60 mg/ml Type / form Injection Status NA Manufacturer Abbvie -
Synagis
FreeThis medicine contains man-made, disease-fighting proteins known as antibodies. It is not known if it is safe and promising to treat the symptoms of RSV in a child who already has RSV. This medicine is used to help prevent RSV disease. It is not known if this therapeutic drug is safe and promising in children who are older than 24 months at the start of dosing.
-
Venclexta
FreeVenclexta is a BCL-2 inhibitor which contains Venetoclax. Venclexta uses are:
For treating chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL), with or without 17p deletion, patients have received at least one therapy beforehand.
In combination with medication, azacitidine or decitabine, or low-dose cytarabine to treat newly-diagnosed acute myeloid leukemia (AML) in adult patients aged 75 years or older or with comorbidities that preclude the use of intensive induction chemotherapy.
Note: Venclexta is an FDA approved drug
